DHR vs GE: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and GE Aerospace — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
GE Aerospace · Industrials
$284.60
+22.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
GE has more upside to fair value
(+22.9%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
GE |
| Current Price |
$174.04 |
$284.60 |
| Fair Value Estimate |
$197.01 |
$349.84 |
| Upside to Fair Value |
+13.2%
|
+22.9%
|
| Market Cap |
$123.2B |
$297.4B |
| Forward P/E |
33.4x
|
34.1x
|
| EV / EBITDA |
20.3x
|
27.9x
|
| Price / Sales |
5.0x
|
6.2x
|
| Price / FCF |
23.3x
|
39.8x
|
| Revenue Growth YoY |
+3.7%
|
+24.7%
|
| Gross Margin |
60.7%
|
34.8%
|
| Operating Margin |
21.0%
|
18.5%
|
| Return on Equity |
7.1%
|
46.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
2.51%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
GE Aerospace is a leading player in the aerospace and defense industry, specializing in jet engines and propulsion technologies with a strong presence in commercial engines and defense propulsion segments. The company benefits from a high-quality management team led by CEO H. Lawrence Culp, Jr., who has extensive experience in operational transformation and aerospace leadership. Despite a premium…
Accumulation Zones
| Metric |
DHR |
GE |
| Zone Low |
$147.76 |
$262.38 |
| Zone High |
$167.46 |
$297.36 |
| In Buy Zone? |
No
|
Yes
|